Lenvatinib

From IDWiki
  • Multiple receptor tyrosine kinase inhibitor (TKI) that inhibits VEGF receptors
  • Indicated for thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma
  • Hypertension is a common side effect
  • Other adverse effects include heart failure, QT prolongation, renal failure, proteinuria, diarrhea, poor wound healing and fistula formation